Acorah Software Products - Accounts Production 15.0.600 false true 31 December 2022 1 January 2022 false 1 January 2023 31 December 2023 31 December 2023 09622983 Rohan Agarwal Testbusters UK Holdings Ltd Ludovico Callerio Testbusters SRL false iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09622983 2022-12-31 09622983 2023-12-31 09622983 2023-01-01 2023-12-31 09622983 frs-core:CurrentFinancialInstruments 2023-12-31 09622983 frs-core:Non-currentFinancialInstruments 2023-12-31 09622983 frs-core:BetweenOneFiveYears 2023-12-31 09622983 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-12-31 09622983 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-01-01 2023-12-31 09622983 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2022-12-31 09622983 frs-core:MotorVehicles 2023-12-31 09622983 frs-core:MotorVehicles 2023-01-01 2023-12-31 09622983 frs-core:MotorVehicles 2022-12-31 09622983 frs-core:PlantMachinery 2023-12-31 09622983 frs-core:PlantMachinery 2023-01-01 2023-12-31 09622983 frs-core:PlantMachinery 2022-12-31 09622983 frs-core:WithinOneYear 2023-12-31 09622983 frs-core:ShareCapital 2023-12-31 09622983 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31 09622983 frs-bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 09622983 frs-bus:FilletedAccounts 2023-01-01 2023-12-31 09622983 frs-bus:SmallEntities 2023-01-01 2023-12-31 09622983 frs-bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 09622983 frs-bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 09622983 frs-bus:OrdinaryShareClass1 2023-01-01 2023-12-31 09622983 frs-bus:OrdinaryShareClass1 2023-12-31 09622983 1 2023-01-01 2023-12-31 09622983 frs-core:DeferredTaxation 2023-01-01 2023-12-31 09622983 frs-core:DeferredTaxation 2023-12-31 09622983 frs-bus:Director1 2023-01-01 2023-12-31 09622983 frs-bus:Director2 2023-01-01 2023-12-31 09622983 frs-bus:Director3 2023-01-01 2023-12-31 09622983 frs-countries:EnglandWales 2023-01-01 2023-12-31 09622983 2021-12-31 09622983 2022-12-31 09622983 2022-01-01 2022-12-31 09622983 frs-core:CurrentFinancialInstruments 2022-12-31 09622983 frs-core:Non-currentFinancialInstruments 2022-12-31 09622983 frs-core:BetweenOneFiveYears 2022-12-31 09622983 frs-core:WithinOneYear 2022-12-31 09622983 frs-core:ShareCapital 2022-12-31 09622983 frs-core:RetainedEarningsAccumulatedLosses 2022-12-31 09622983 frs-bus:OrdinaryShareClass1 2022-01-01 2022-12-31
Registered number: 09622983
Medox Tutors Limited
Unaudited Financial Statements
For The Year Ended 31 December 2023
Sterling Accounting Solutions Ltd
Chartered Accountants
SAS House
Chipperfield Road
Kings Langley
Hertfordshire
WD4 9JB
Unaudited Financial Statements
Contents
Page
Company Information 1
Accountants' Report 2
Statement of Financial Position 3—4
Notes to the Financial Statements 5—10
Page 1
Company Information
Directors Rohan Agarwal
Testbusters UK Holdings Ltd
Ludovico Callerio
Company Number 09622983
Registered Office SAS House
Chipperfield Road
Kings Langley
Hertfordshire
WD4 9JB
Accountants Sterling Accounting Solutions Ltd
Chartered Accountants
SAS House
Chipperfield Road
Kings Langley
Hertfordshire
WD4 9JB
Page 1
Page 2
Accountants' Report
Chartered Accountants' report to the directors on the preparation of the unaudited statutory accounts of Medox Tutors Limited For The Year Ended 31 December 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Medox Tutors Limited for the year ended 31 December 2023 which comprise the Income Statement, the Statement of Financial Position and the related notes from the company's accounting records and from information and explanations you have given to us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/membership/regulations-standards-and-guidance.
This report is made solely to the directors of Medox Tutors Limited , as a body, in accordance with the terms of our engagement letter dated . Our work has been undertaken solely to prepare for your approval the accounts of Medox Tutors Limited and state those matters that we have agreed to state to the directors of Medox Tutors Limited , as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Medox Tutors Limited and its directors, as a body, for our work or for this report.
It is your duty to ensure that Medox Tutors Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit or loss of Medox Tutors Limited . You consider that Medox Tutors Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit of the accounts of Medox Tutors Limited . For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the financial statements.
Signed
Sterling Accounting Solutions Ltd
19/09/2024
Sterling Accounting Solutions Ltd
Chartered Accountants
SAS House
Chipperfield Road
Kings Langley
Hertfordshire
WD4 9JB
Page 2
Page 3
Statement of Financial Position
Registered number: 09622983
2023 2022
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 55,896 72,344
Tangible Assets 5 74,348 5,031
130,244 77,375
CURRENT ASSETS
Debtors 6 289,372 249,047
Cash at bank and in hand 1,254,049 863,262
1,543,421 1,112,309
Creditors: Amounts Falling Due Within One Year 7 (416,482 ) (187,721 )
NET CURRENT ASSETS (LIABILITIES) 1,126,939 924,588
TOTAL ASSETS LESS CURRENT LIABILITIES 1,257,183 1,001,963
Creditors: Amounts Falling Due After More Than One Year 8 (78,896 ) (24,167 )
PROVISIONS FOR LIABILITIES
Deferred Taxation 10 (18,587 ) -
NET ASSETS 1,159,700 977,796
CAPITAL AND RESERVES
Called up share capital 12 100 100
Income Statement 1,159,600 977,696
SHAREHOLDERS' FUNDS 1,159,700 977,796
Page 3
Page 4
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Income Statement.
On behalf of the board
Rohan Agarwal
Director
Ludovico Callerio
Director
19/09/2024
The notes on pages 5 to 10 form part of these financial statements.
Page 4
Page 5
Notes to the Financial Statements
1. General Information
Medox Tutors Limited is a private company, limited by shares, incorporated in England & Wales, registered number 09622983 . The registered office is SAS House, Chipperfield Road, Kings Langley, Hertfordshire, WD4 9JB.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
These financial statements have been prepared in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland" ("FRS 102") and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Research and Development
Development expenditure incurred is capitalised as an intangible asset only when all of the
following criteria are met:

• It is technically feasible to complete the intangible asset so that it will be available for use or sale;
• There is the intention to complete the intangible asset and use or sell it;
• There is the ability to use or sell the intangible asset;
• The use or sale of the intangible asset will generate probable future economic benefits;
• There are adequate technical, financial and other resources available to complete the development and to use or sell the intangible asset; and
• The expenditure attributable to the intangible asset during its development can be measured reliably.

Expenditure that does not meet the above criteria is expensed as incurred.

It is amortised to income statement over its estimated economic life of 5 years.
Page 5
Page 6
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 20% reducing balance
Motor Vehicles 8 years straight line
2.5. Leasing and Hire Purchase Contracts
Assets obtained under finance leases are capitalised as tangible fixed assets. Assets acquired under finance leases are depreciated over the shorter of the lease term and their useful lives. Assets acquired under hire purchase contracts are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in the creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the income statement so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.

Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to income statement as incurred.
2.6. Financial Instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price and are subsequently measured as follows: Debt instruments are subsequently measured at amortised cost and commitments to receive a loan and to make a loan to another entity are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment.
All other financial instruments, including derivatives, are initially recognised at fair value, which is normally the transaction price and are subsequently measured at fair value, with any changes recognised in profit or loss.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.
All equity instruments regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics.
Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
Page 6
Page 7
2.7. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.8. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 11 (2022: 11)
11 11
4. Intangible Assets
Development Costs
£
Cost
As at 1 January 2023 82,240
As at 31 December 2023 82,240
...CONTINUED
Page 7
Page 8
Amortisation
As at 1 January 2023 9,896
Provided during the period 16,448
As at 31 December 2023 26,344
Net Book Value
As at 31 December 2023 55,896
As at 1 January 2023 72,344
5. Tangible Assets
Plant & Machinery Motor Vehicles Total
£ £ £
Cost
As at 1 January 2023 10,264 - 10,264
Additions 1,203 69,950 71,153
As at 31 December 2023 11,467 69,950 81,417
Depreciation
As at 1 January 2023 5,233 - 5,233
Provided during the period 1,107 729 1,836
As at 31 December 2023 6,340 729 7,069
Net Book Value
As at 31 December 2023 5,127 69,221 74,348
As at 1 January 2023 5,031 - 5,031
6. Debtors
2023 2022
£ £
Due within one year
Trade debtors 9,300 -
Other debtors 27,187 248,602
Directors' loan accounts 2,069 445
Amounts owed by group undertakings 250,816 -
289,372 249,047
Page 8
Page 9
7. Creditors: Amounts Falling Due Within One Year
2023 2022
£ £
Net obligations under finance lease and hire purchase contracts 5,221 -
Trade creditors 13,086 3,574
Bank loans and overdrafts 10,000 10,000
Corporation tax 35 -
Other creditors 388,140 174,147
416,482 187,721
8. Creditors: Amounts Falling Due After More Than One Year
2023 2022
£ £
Net obligations under finance lease and hire purchase contracts 64,729 -
Bank loans 14,167 24,167
78,896 24,167
9. Obligations Under Finance Leases and Hire Purchase
2023 2022
£ £
The future minimum finance lease payments are as follows:
Not later than one year 5,221 -
Later than one year and not later than five years 64,729 -
69,950 -
69,950 -
10. Deferred Taxation
The provision for deferred tax is made up as follows:
2023 2022
£ £
Other timing differences 18,587 -
11. Provisions for Liabilities
Deferred Tax Total
£ £
Deferred taxation 18,587 18,587
Balance at 31 December 2023 18,587 18,587
Page 9
Page 10
12. Share Capital
2023 2022
Allotted, called up and fully paid £ £
1,000,000 Ordinary Shares of £ 0.0001 each 100 100
13. Related Party Transactions
At the year end £367 (2022: £818) was owed to RAR Medical Services Limited, a company in which Rohan Agarwal is a director. The balance is included within other creditors.
At the year end £9,619 (2022: £10,927) was owed from 6Med Limited, a company in which Rohan Agarwal and Ludovico Callerio are directors. The balance is included within other debtors.
At the year end £839 (2022: £Nil) was owed from Exams Ninja Limited, a company in which Rohan Agarwal and Ludovico Callerio are directors. The balance is included within other debtors.
At the year end £90 (2022: £Nil) was owed from Medit Education Limited, a company in which Ludovico Callerio is a director. The balance is included within other debtors.
At the year end £101 (2022: £Nil) was owed from Erudical Limited, a company in which Rohan Agarwal is a director. The balance is included within other debtors.
At the year end £Nil (2022: £201,375) was owed from Agarsen Properties Limited, a company in which Rohan Agarwal is a director.
14. Parent Undertaking and Controlling Party
The company's immediate and parent undertaking is Testbusters UK Holdings Ltd . Testbusters UK Holdings Ltd was incorporated in England and Wales. 
The ultimate controlling party is Testbusters SRL who controls 100% of the shares of Testbusters UK Holdings Ltd .
Page 10